A. Miyamoto

Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling

Sho Tsukamoto, Takato Mizuta, Mai Fujimoto et al. · Scientific Reports · 2014 · 117 citations · Full text

Structural control of evaporated lead-phthalocyanine films

A. Miyamoto, Katsuhiro Nichogi, Akira Taomoto et al. · Thin Solid Films · 1995 · 50 citations

Materials Engineering, Organic Charge-transfer Compound, Engineering +5

In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid

Isao Shibuya, Masamichi Takami, A. Miyamoto et al. · Pathology & Oncology Research · 2017 · 45 citations

Bone Disease, Zoledronic Acid, Bone Health +11

Reentrant behavior in the pressure-temperature dependence of the resistivity of (DMeO-DCNQI)2Cu

H. Kobayashi, A. Miyamoto, Reìzo Kato et al. · Solid State Communications · 1989 · 36 citations

Materials Science, Reentrant Behavior, Engineering +9

Mutant Activin-Like Kinase 2 in Fibrodysplasia Ossificans Progressiva are Activated via T203 by BMP Type II Receptors

Mai Fujimoto, Satoshi Ohte, Kenji Osawa et al. · Molecular Endocrinology · 2014 · 26 citations · Full text

Mechanobiology, Fop Patients, Sclerostin +15